Concepedia

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

Evald Høj Christiansen, Lisette Okkels Jensen, Per Thayssen, Hans–Henrik Tilsted, Lars Romer Krusell, Knud Nørregaard Hansen, Anne Kaltoft, Steen Dalby Kristensen, Hans Erik Bøtker, Christian Juhl Terkelsen,

The Lancet · 2013 · 203 citations · 35 references

DOIFull text

Open access

Concepts

References

35

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

, , +15

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

, , +13

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

David Moher, Kenneth F. Schulz, Douglas G. Altman · The Lancet · 2001 · 5.4K citations · Full text

, , +12

Universal Definition of Myocardial Infarction

Kristian Thygesen, Joseph S. Alpert, Harvey D. White · Circulation · 2007 · 4.2K citations

, , +12

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma et al. · New England Journal of Medicine · 2003 · 4.2K citations · Full text

, , +16